Funds holding Abivax SA
ISIN US00370M1036 · France · LEI 969500D8TMNB184OJU95
- Fund holders
- 92
- Of which ETFs
- 13 79 other funds
- Value held
- 633.4M $ 45.3M SEK · 47.8K €
Other securities from the same issuer : Abivax SA (FR0012333284)
92 funds hold this company: 90 declare it in a regulatory filing, and this table serves those page by page; 2 more are read from the reports their funds publish, and are not in it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Lord Abbett Growth Leaders Fund LORD ABBETT SECURITIES TRUST | 468,485 | 55M $ | 0.73 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 407,954 | 45.4M $ | 0.42 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 367,461 | 40.9M $ | 0.50 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 343,880 | 41.7M $ | 0.05 % | as of Feb 28, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 320,311 | 35.7M $ | 2.25 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 301,600 | 36.6M $ | 0.68 % | as of Feb 28, 2026 ↗ |
| Harbor Small Cap Growth Fund HARBOR FUNDS | 287,800 | 33.8M $ | 1.31 % | as of Apr 30, 2026 ↗ |
| ALGER SPECTRA FUND ALGER FUNDS II | 280,615 | 32.9M $ | 0.77 % | as of Apr 30, 2026 ↗ |
| ALGER FOCUS EQUITY FUND ALGER INSTITUTIONAL FUNDS | 257,673 | 30.2M $ | 0.50 % | as of Apr 30, 2026 ↗ |
| LORD ABBETT DEVELOPING GROWTH FUND INC LORD ABBETT DEVELOPING GROWTH FUND, INC. | 183,074 | 21.5M $ | 0.97 % | as of Apr 30, 2026 ↗ |
| ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND ALGER INSTITUTIONAL FUNDS | 169,998 | 20M $ | 0.60 % | as of Apr 30, 2026 ↗ |
| ALGER SMALL CAP FOCUS FUND ALGER FUNDS | 152,474 | 17.9M $ | 2.27 % | as of Apr 30, 2026 ↗ |
| ALGER CAPITAL APPRECIATION FUND ALGER FUNDS | 141,390 | 16.6M $ | 0.62 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 141,080 | 16.6M $ | 1.60 % | as of Apr 30, 2026 ↗ |
| Invesco Main Street Mid Cap Fund AIM Growth Series (Invesco Growth Series) | 113,349 | 12.6M $ | 0.53 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 100,500 | 11.8M $ | 0.41 % | as of Apr 30, 2026 ↗ |
| SmallCap Fund Principal Funds, Inc | 97,900 | 11.5M $ | 0.55 % | as of Apr 30, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 97,266 | 11.8M $ | 0.05 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 95,404 | 10.6M $ | 0.08 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 92,200 | 11.2M $ | 0.05 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Hedge Industry VIP ETF Goldman Sachs ETF Trust | 72,921 | 8.8M $ | 1.95 % | as of Feb 28, 2026 ↗ |
| Bridge Builder Tax Managed Small/Mid Cap Fund Bridge Builder Trust | 65,443 | 7.3M $ | 0.24 % | as of Mar 31, 2026 ↗ |
| ALGER MID CAP FOCUS FUND ALGER FUNDS | 54,840 | 6.4M $ | 2.03 % | as of Apr 30, 2026 ↗ |
| Lord Abbett Growth Opportunities Fund LORD ABBETT RESEARCH FUND INC | 50,270 | 6.1M $ | 0.89 % | as of Feb 28, 2026 ↗ |
| Alger Large Cap Growth Portfolio ALGER PORTFOLIOS | 45,671 | 5.1M $ | 1.32 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 45,200 | 5.5M $ | 0.38 % | as of Feb 27, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 45,000 | 5M $ | 0.75 % | as of Mar 31, 2026 ↗ |
| Alger Capital Appreciation Portfolio ALGER PORTFOLIOS | 41,211 | 4.6M $ | 0.70 % | as of Mar 31, 2026 ↗ |
| Mercer US Small/Mid Cap Equity Fund Mercer Funds | 39,680 | 4.4M $ | 0.26 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 35,688 | 4.3M $ | 0.02 % | as of Feb 28, 2026 ↗ |
| Lord Abbett International Opportunities Fund LORD ABBETT SECURITIES TRUST | 31,000 | 3.6M $ | 1.05 % | as of Apr 30, 2026 ↗ |
| ALGER SMALL CAP GROWTH FUND ALGER FUNDS | 27,149 | 3.2M $ | 1.67 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 24,954 | 2.8M $ | 0.42 % | as of Mar 31, 2026 ↗ |
| HealthInvest Sustainable Healthcare Atle Fund Management AB | 24,916 | 26.3M SEK | 0.82 % | as of Mar 31, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 24,000 | 2.7M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Tax-Managed U.S. Mid & Small Cap Fund RUSSELL INVESTMENT CO | 22,964 | 2.7M $ | 0.13 % | as of Apr 30, 2026 ↗ |
| ALGER MID CAP GROWTH FUND ALGER FUNDS | 22,166 | 2.6M $ | 0.93 % | as of Apr 30, 2026 ↗ |
| Alger Dynamic Opportunities Fund ALGER FUNDS II | 20,093 | 2.4M $ | 1.06 % | as of Apr 30, 2026 ↗ |
| Alger Small Cap Growth Portfolio ALGER PORTFOLIOS | 19,561 | 2.2M $ | 1.66 % | as of Mar 31, 2026 ↗ |
| Invesco Health Care Fund AIM Investment Funds (Invesco Investment Funds) | 18,814 | 2.2M $ | 0.20 % | as of Apr 30, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 18,044 | 19M SEK | 1.91 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 17,914 | 2.2M $ | 0.30 % | as of Feb 28, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 17,718 | 2M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Alger Mid Cap 40 ETF Alger ETF Trust | 14,520 | 1.6M $ | 1.37 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 14,104 | 1.7M $ | 0.02 % | as of Feb 28, 2026 ↗ |
| International Small Company Fund Principal Funds, Inc | 13,789 | 1.7M $ | 0.36 % | as of Feb 28, 2026 ↗ |
| Alger Mid Cap Growth Portfolio ALGER PORTFOLIOS | 12,868 | 1.4M $ | 1.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Nordic Fund Fidelity Investment Trust | 12,200 | 1.4M $ | 0.40 % | as of Apr 30, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 11,892 | 1.4M $ | 0.15 % | as of Apr 30, 2026 ↗ |
| AdvisorShares Dorsey Wright ADR ETF AdvisorShares Trust | 11,802 | 1.3M $ | 2.91 % | as of Mar 31, 2026 ↗ |
| NICHOLAS PARTNERS SMALL CAP GROWTH FUND ADVISORS' INNER CIRCLE III | 11,757 | 1.3M $ | 0.88 % | as of Mar 31, 2026 ↗ |
| SIMT Large Cap Growth Fund SEI INSTITUTIONAL MANAGED TRUST | 10,847 | 1.2M $ | 0.09 % | as of Mar 31, 2026 ↗ |
| ALGER SMALL CAP GROWTH INSTITUTIONAL FUND ALGER INSTITUTIONAL FUNDS | 10,152 | 1.2M $ | 1.67 % | as of Apr 30, 2026 ↗ |
| Multi-Manager U.S. Small Cap Equity Fund Goldman Sachs Trust II | 9,985 | 1.2M $ | 0.33 % | as of Apr 30, 2026 ↗ |
| ALGER HEALTH SCIENCES FUND ALGER FUNDS | 9,738 | 1.1M $ | 1.88 % | as of Apr 30, 2026 ↗ |
| Lord Abbett Focused Growth Fund LORD ABBETT SECURITIES TRUST | 9,602 | 1.1M $ | 0.69 % | as of Apr 30, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 9,016 | 1M $ | 0.44 % | as of Mar 31, 2026 ↗ |
| SmallCap Account Principal Variable Contract Funds, Inc | 8,700 | 968.7K $ | 0.57 % | as of Mar 31, 2026 ↗ |
| SIMT Large Cap Fund SEI INSTITUTIONAL MANAGED TRUST | 8,321 | 926.5K $ | 0.07 % | as of Mar 31, 2026 ↗ |
| Harbor Health Care ETF Harbor ETF Trust | 8,304 | 974.7K $ | 3.54 % | as of Apr 30, 2026 ↗ |
| Federated Hermes International Small-Mid Company Fund Federated Hermes World Investment Series, Inc. | 7,700 | 933.9K $ | 0.18 % | as of Feb 28, 2026 ↗ |
| SMALL CAP EQUITY FUND GuideStone Funds | 7,687 | 855.9K $ | 0.10 % | as of Mar 31, 2026 ↗ |
| Invesco V.I. Main Street Mid Cap Fund AIM Variable Insurance Funds (Invesco Variable Insurance Funds) | 7,040 | 783.9K $ | 0.52 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 6,483 | 721.9K $ | 0.45 % | as of Mar 31, 2026 ↗ |
| AMG TimesSquare Small Cap Growth Fund AMG Funds | 5,754 | 640.7K $ | 0.69 % | as of Mar 31, 2026 ↗ |
| Developing Growth Portfolio LORD ABBETT SERIES FUND INC | 5,712 | 636K $ | 1.09 % | as of Mar 31, 2026 ↗ |
| Baron Health Care Fund BARON SELECT FUNDS | 5,500 | 612.4K $ | 0.51 % | as of Mar 31, 2026 ↗ |
| Global X Guru Index ETF GLOBAL X FUNDS | 5,013 | 588.4K $ | 1.01 % | as of Apr 30, 2026 ↗ |
| Growth Opportunities Portfolio LORD ABBETT SERIES FUND INC | 4,932 | 549.2K $ | 0.86 % | as of Mar 31, 2026 ↗ |
| State Street Institutional Small-Cap Equity Fund STATE STREET INSTITUTIONAL FUNDS | 4,780 | 532.3K $ | 0.11 % | as of Mar 31, 2026 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 4,314 | 506.4K $ | 0.17 % | as of Apr 30, 2026 ↗ |
| ALGER MID CAP GROWTH INSTITUTIONAL FUND ALGER INSTITUTIONAL FUNDS | 4,218 | 495.1K $ | 0.91 % | as of Apr 30, 2026 ↗ |
| Franklin Alternative Strategies Fund Franklin Alternative Strategies Funds | 3,794 | 460.1K $ | 0.09 % | as of Feb 27, 2026 ↗ |
| Large Company Growth Portfolio Wilshire Mutual Funds Inc | 3,521 | 392.1K $ | 0.16 % | as of Mar 31, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 3,424 | 381.3K $ | 0.97 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3,337 | 404.7K $ | 0.53 % | as of Feb 28, 2026 ↗ |
| ALGER 35 FUND ALGER FUNDS | 3,192 | 374.7K $ | 0.86 % | as of Apr 30, 2026 ↗ |
| SIIT LARGE CAP FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 2,978 | 361.2K $ | 0.06 % | as of Feb 28, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 2,814 | 313.3K $ | 0.15 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,726 | 330.6K $ | 0.36 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Multi-Manager Global Equity Fund Goldman Sachs Trust II | 2,121 | 249K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| Lord Abbett Health Care Fund LORD ABBETT SECURITIES TRUST | 1,296 | 152.1K $ | 1.87 % | as of Apr 30, 2026 ↗ |
| Fidelity Healthy Future Fund Fidelity Summer Street Trust | 747 | 87.7K $ | 0.59 % | as of Apr 30, 2026 ↗ |
| Russell Investments U.S. Small Cap Equity ETF Russell Investments Exchange Traded Funds | 718 | 79.9K $ | 0.16 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 258 | 28.7K $ | 0.19 % | as of Mar 31, 2026 ↗ |
| State Street Small-Cap Equity V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 227 | 25.3K $ | 0.12 % | as of Mar 31, 2026 ↗ |
| Simplify Health Care ETF Simplify Exchange Traded Funds | 220 | 24.5K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Lord Abbett International Growth Fund LORD ABBETT TRUST I | 110 | 12.9K $ | 0.23 % | as of Apr 30, 2026 ↗ |
| NPF Core Equity ETF Elevation Series Trust | 12 | 1.4K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 47.8K € | 1.30 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Harbor Health Care ETF Harbor ETF Trust | 3.54 % | as of Apr 30, 2026 ↗ |
| AdvisorShares Dorsey Wright ADR ETF AdvisorShares Trust | 2.91 % | as of Mar 31, 2026 ↗ |
| ALGER SMALL CAP FOCUS FUND ALGER FUNDS | 2.27 % | as of Apr 30, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 2.25 % | as of Mar 31, 2026 ↗ |
| ALGER MID CAP FOCUS FUND ALGER FUNDS | 2.03 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Hedge Industry VIP ETF Goldman Sachs ETF Trust | 1.95 % | as of Feb 28, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 1.91 % | as of Mar 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 1.90 % | as of Sep 30, 2025 ↗ |
| ALGER HEALTH SCIENCES FUND ALGER FUNDS | 1.88 % | as of Apr 30, 2026 ↗ |
| Lord Abbett Health Care Fund LORD ABBETT SECURITIES TRUST | 1.87 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 87 | +7 | 5,450,896 | -5.1 % |
| 2026Q1 | 80 | +24 | 5,746,173 | +41.6 % |
| 2025Q4 | 56 | +38 | 4,057,228 | +227.3 % |
| 2025Q3 | 18 | +15 | 1,239,552 | +137.3 % |
| 2025Q2 | 3 | 0 | 522,299 | +0.2 % |
| 2025Q1 | 3 | 0 | 521,122 | +3.5 % |
| 2024Q4 | 3 | +1 | 503,730 | +1.8 % |
| 2024Q3 | 2 | 0 | 494,689 | +0.7 % |
| 2024Q2 | 2 | -4 | 491,044 | -40.4 % |
| 2024Q1 | 6 | +4 | 823,336 | +110.9 % |
| 2023Q4 | 2 | 390,400 |
Institutional managers
251 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| TCG Crossover Management, LLC | 6,481,085 | 721.7M $ | as of Mar 31, 2026 |
| UBS Group AG | 4,547,406 | 506.4M $ | as of Mar 31, 2026 |
| Darwin Global Management, Ltd. | 3,468,657 | 352.1M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,704,958 | 189.8M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,500,000 | 167M $ | as of Mar 31, 2026 |
| Caligan Partners LP | 1,461,924 | 162.8M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 1,394,019 | 155.2M $ | as of Mar 31, 2026 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1,322,938 | 147.3M $ | as of Mar 31, 2026 |
| FMR LLC | 1,286,373 | 143.2M $ | as of Mar 31, 2026 |
| Helikon Investments Ltd | 1,013,324 | 112.8M $ | as of Mar 31, 2026 |
| Eversept Partners, LP | 934,423 | 104M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 878,829 | 98M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 875,796 | 97.5M $ | as of Mar 31, 2026 |
| LORD, ABBETT & CO. LLC | 854,920 | 95.2K $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 772,473 | 86M $ | as of Mar 31, 2026 |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 765,915 | 85.3M $ | as of Mar 31, 2026 |
| Cormorant Asset Management, LP | 760,000 | 84.6M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 735,729 | 81.9M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 691,670 | 77K $ | as of Mar 31, 2026 |
| Octagon Capital Advisors LP | 677,000 | 75.4M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 675,000 | 75.2M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 637,736 | 71M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 635,066 | 64.5M $ | as of Mar 31, 2026 |
| Ensign Peak Advisors, Inc | 631,838 | 70.4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 605,992 | 67.5M $ | as of Mar 31, 2026 |
Declared shareholders of Abivax SA
1 beneficial ownership filing. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Sofinnova Crossover I SLP and 6 others | 6.70 % | 5,499,478 | as of May 7, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Funds holding Abivax SA". https://titelia.com/en/stocks/abivax-sa-US00370M1036